Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedJul 3, 2019Mitomycin Preservative Free IrrigationLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1420-2019Class IITerminatedJul 3, 2019Lidocaine 0.5%/Phenylephrine 0.75% P.F. INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1419-2019Class IITerminatedJul 3, 2019Isoproterenol HCL in D5WLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1418-2019Class IITerminatedJul 3, 2019Isoproterenol HCL in D5WLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1417-2019Class IITerminatedJul 3, 2019Isoproterenol HCL in D5WLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1416-2019Class IITerminatedJul 3, 2019Droperidol Injectable Sterile SolutionLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1415-2019Class IITerminatedJul 3, 2019Dexamethasone Sodium Phosphate Preservative Free Sterile Solution for INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1414-2019Class IITerminatedJul 3, 2019ChlorproMAZINE HCL INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1413-2019Class IITerminatedJul 3, 2019Brilliant Blue Ophthalmic PF INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1412-2019Class IITerminatedJul 3, 2019Atropine Sulfate PF INJLack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations...Premier Pharmacy Labs Inc · D-1411-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1453-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 1.5 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1452-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1451-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1450-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1449-2019Class IITerminatedJun 26, 2019MethylPREDNISolone TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1448-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 1 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1447-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 0.5 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1446-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 0.25 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1445-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochoride Tablets 0.25 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1444-2019Class IITerminatedJun 26, 2019Pramipexole DihydrochlorideTablets 0.125 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1443-2019Class IITerminatedJun 26, 2019Pramipexole Dihydrochloride Tablets 0.125 mgCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1442-2019Class IITerminatedJun 26, 2019Anastrozole TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1441-2019Class IITerminatedJun 26, 2019ANASTROZOLE TabletsCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.Zydus Pharmaceuticals USA Inc · D-1440-2019Class IITerminatedJun 26, 2019Robafen DMCGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).Preferred Pharmaceuticals, Inc · D-1410-2019Class IITerminatedJun 26, 2019Cetirizine Oral Solution 1 mg/mLcGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential...P & L Developments, LLC · D-1409-2019Class IITerminatedJun 26, 2019Cetirizine Oral Solution 1 mg/mLcGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential...P & L Developments, LLC · D-1408-2019Class IITerminatedJun 26, 2019Cetirizine HCL Oral Solution 1 mg/mLcGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential...P & L Developments, LLC · D-1407-2019Class IITerminatedJun 26, 2019Anastrozole TabletsGMP Deviations: Potential cross contamination due to cleaning procedure failure.American Health Packaging · D-1394-2019Class IIITerminatedJun 26, 2019QUIK-CARE Aerosol Foam Hand SanitizerIncorrect/undeclared excipients: Hand sanitizer was made using the wrong alcohol raw material.Ecolab Inc · D-1393-2019Class IIITerminatedJun 26, 2019MyorisanLabeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.Akorn Inc · D-1392-2019Class IIITerminatedJun 26, 2019Betamethasone Dipropionate Ointment USPFailed Impurities/Degradation SpecificationsTeligent Pharma, Inc. · D-1391-2019Class IITerminatedJun 26, 2019Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mgTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1390-2019Class IITerminatedJun 26, 2019Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release TabletsTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1389-2019Class IITerminatedJun 26, 2019Allergy Relief DTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1388-2019Class IITerminatedJun 26, 2019Allergy Relief DTesting of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the...Sun Pharmaceutical Industries, Inc. · D-1387-2019Class IITerminatedJun 19, 2019Senna (sennosides 8.8 mg) Syrup 8 fl ozFailed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reportedGeritrex, LLC · D-1437-2019Class IITerminatedJun 19, 2019Senna (sennosides 8.8 mg) SyrupFailed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reportedGeritrex, LLC · D-1436-2019Class IITerminatedJun 19, 2019SevofluraneFailed Stability SpecificationsBaxter Healthcare Corporation · D-1435-2019Class IITerminatedJun 19, 2019Sn-Pyrophosphate KitLack of Processing Controls.Synthetopes Inc · D-1406-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.